Acute Kidney Injury Induced by Immune Checkpoint Inhibitors

Background: Recent advances in immune therapy have focused on several agents that target tumor suppression; specifically, use of immune checkpoint inhibitors (ICIs), such as ipilimumab, pembrolizumab, and nivolumab, has become an important strategy in cancer therapy as they improve outcomes in malig...

全面介紹

書目詳細資料

Principais autores:	Ruixue Tian, Jin Liang, Rongshan Li, Xiaoshuang Zhou
格式:	Artigo
語言:	Inglês
出版:	Karger Publishers 2022-04-01
叢編:	Kidney Diseases
主題:	acute kidney injury immune checkpoint inhibitors acute interstitial nephritis immune-related adverse events
在線閱讀:	https://www.karger.com/Article/FullText/520798
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!